CBX3 and colorectal carcinoma: One study highlighted the CBX3/NRF2/GPX2 axis, showing that CBX3 upregulates NRF2 by inhibiting CUL3 transcription, which in turn enhances GPX2 expression, thereby suppressing ferroptosis and promoting multidrug resistance in CRC cells.121